Fluorine-18 FDG-PET in detecting local recurrence and distant metastases in breast cancer - Taiwanese experiences

Cancer Investigation

Volumn 20, Issue 5-6, 2002, Pages 725-729

  Lin, Wan Yu ^a,b   Tsai, Shih Chuan ^c   Cheng, Kai Yuan ^b   Yen, Ruoh Fang ^d   Kao, Chia Hung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b Chung Tai College of Medical Technology   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Breast cancer; FDG PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BREAST TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; SCINTISCANNING; TUMOR RECURRENCE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036052171     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120003541     Document Type: Article

References (20)

1. Adler, L.P.; Crowe, J.P.; al-Kaisi, N.K.; et al. Evaluation of Breast Masses and Axillary Lymph Nodes with [F-18] 2-Deoxy-2-Fluoro-D-Glucose PET. Radiology 1993, 187, 743-750.
2. Avril, N.; Dose, J.; Janicke, F.; et al. Metabolic Characterization of Breast Tumors with Positron Emission Tomography Using F-18 Fluorodeoxyglucose. J. Clin. Oncol. 1996, 14, 1848-1857.
3. Hawkins, R.A.; Hoh, C.; Glaspy, J.; et al. Positron Emission Tomography Scanning in Cancer. Cancer Investig. 1994, 12, 74-87.
4. Crowe, J.P.J.; Adler, L.P.; Shenk, R.R.; et al. Positron Emission Tomography and Breast Masses: Comparison with Clinical Mammographic, and Pathological Findings. Ann. Surg. Oncol. 1994, 1, 132-140.
5. Boerner, A.R.; Weckesser, M.; Herzog, H.; et al. Optimal Scan Time for Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer. Eur. J. Nucl. Med. 1999, 26, 226-230.
6. Bender, H.; Kirst, J.; Palmedo, H.; et al. Value of 18 Fluoro-deoxyglucose Positron Emission Tomography in the Staging of Recurrent Breast Carcinoma. Anticancer Res. 1997, 17, 1687-1692.
7. Casey, M.J.; Gupta, N.C.; Muths, C.K. Experience with Positron Emission Tomography (PET) in Patients with Ovarian Cancer. Gynecol. Oncol. 1994, 53, 331-338.
8. Schiepers, C.; Penninckx, F.; De Vadder, N.; et al. Contribution of PET in the Diagnosis of Recurrent Colorectal Cancer: Comparison with Conventional Imaging. Eur. J. Surg. Oncol. 1995, 21, 517-522.
9. Lapela, M.; Grenman, R.; Kurki, T.; et al. Head and Neck Cancer: Detection of Recurrence with PET and 2-18F-Fluoro-2-Deoxy-D-Glucose. Radiology 1995, 197, 205-211.
10. Steinert, H.C.; Boni, R.A.H.; Buck, A.; et al. Malignant Melanoma: Staging with Whole-Body Positron Emission Tomography and 2-18F-Fluoro-2-Deoxy-D-Glucose. Radiology 1995, 195, 705-709.
11. Inoue, T.; Kim, E.E.; Komaki, R.; et al. Detecting Recurrent or Residual Lung Cancer with FDG-PET. J. Nucl. Med. 1995, 36, 788-793.
12. Moon, D.H.; Maddahi, J.; Silverman, D.H.; et al. Accuracy of Whole-Body Fluorine-18-FDG PET for the Detection of Recurrent or Metastatic Breast Carcinoma. J. Nucl. Med. 1998, 39, 431-435.
13. Hathaway, P.B.; Mankoff, D.A.; Maravilla, K.R. Value of Combined FDG PET and MR Imaging in the Evaluation of Suspected Recurrent Local-Regional Breast Cancer: Preliminary Experience. Radiology 1999, 210, 807-814.
14. Bakheet, S.M.; Saleem, M.; Powe, J.; et al. F-18 Fluorodeoxyglucose Chest Uptake in Lung Inflammation and Infection. Clin. Nucl. Med. 2000, 25, 273-278.
15. Shreve, P.D.; Anzai, Y.; Wahl, R.L. Pitfalls in Oncologic Diagnosis with FDG PET Imaging: Physiologic and Benign Variants. Radiographics 1999, 19, 61-77.
16. Tse, N.Y.; Hoh, K.; Hawkins, R.A.; et al. The Application of Positron Emission Tomography with Fluorodeoxyglucose to the Evaluation of Breast Disease. Ann. Surg. 1992, 216, 27-34.
17. Wahl, R.L.; Cody, R.L.; Hutchins, G.D.; et al. Primary and Metastatic Breast Carcinoma: Initial Clinical Evaluation with PET with the Radiolabeled Glucose Analogue 2-F-18-Fluoro-2-Deoxy-D-Glucose. Radiology 1991, 179, 765-770.
18. Jones, H.A.; Clarck, R.J.; Rhodes, C.G.; et al. In Vivo Measurement of Neutrophils Activity in Experimental Lung Inflammation. Am. J. Respir. Crit. Care Med. 1994, 149, 1635-1639.
19. Schuster, D.P. The Evaluation of Lung Infection with PET. Semin. Nucl. Med. 1998, 28, 341-351.
20. Meyer, M.; Gast, T.; Raja, S.; et al. Increased F-18 FDG Accumulation in an Acute Fracture. Clin. Nucl. Med. 1994, 19, 13-14.